Article Versions Notes

Chan LC, Lee HK, Wang L, Wang H, Filler SG, Ciranna A, Abdelhady W, Xiong YQ, Li L, Gonzales RA, et al. Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human Staphylococcus aureus Bacteremia. Antibiotics. 2026; 15(4):332. https://doi.org/10.3390/antibiotics15040332

Chan, Liana C., Hong K. Lee, Ling Wang, Huiyuan Wang, Scott G. Filler, Alexandra Ciranna, Wessam Abdelhady, Yan Q. Xiong, Liang Li, Rachelle A. Gonzales, and et al. 2026. "Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human Staphylococcus aureus Bacteremia" Antibiotics 15, no. 4: 332. https://doi.org/10.3390/antibiotics15040332

Chan, L. C., Lee, H. K., Wang, L., Wang, H., Filler, S. G., Ciranna, A., Abdelhady, W., Xiong, Y. Q., Li, L., Gonzales, R. A., Ruffin, F., Fowler, V. G., Jr., Bayer, A. S., Proctor, R. A., & Yeaman, M. R., on behalf of the MRSA Systems Immunobiology Group (MSIG). (2026). Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human Staphylococcus aureus Bacteremia. Antibiotics, 15(4), 332. https://doi.org/10.3390/antibiotics15040332